Michael J. Cutler

Michael J. Cutler

Auto-generated profile, based on publicly available information

Michael J. Cutler

Intermountain Heart Institute, Intermountain Medical Center

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2023 in Nature
Verified
Journal Article
Closed access
PDF file
JWJoshua S Weinstock
Joshua S Weinstock
JGJayakrishnan Gopakumar
Jayakrishnan Gopakumar
BBBala Bharathi Burugula
Bala Bharathi Burugula
MUMesbah Uddin
Mesbah Uddin
NJNikolaus Jahn
Nikolaus Jahn
SJSiddhartha Jaiswal
Siddhartha Jaiswal

6 March 2025 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
CRCarolina Roselli
Carolina Roselli
ISIda Surakka
Ida Surakka
MOMorten Olesen
Morten Olesen
GSGardar Sveinbjornsson
Gardar Sveinbjornsson
NMNicholas A Marston
Nicholas A Marston
PEPatrick T Ellinor
Patrick T Ellinor

1 September 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
WYWilliam J. Young
William J. Young
NLNajim Lahrouchi
Najim Lahrouchi
AIAaron Isaacs
Aaron Isaacs
TDThuyVy Duong
ThuyVy Duong
LFLuisa Foco
Luisa Foco
PMPatricia B. Munroe
Patricia B. Munroe
The QT interval is an electrocardiographic measure representing the sum of ventricular depolarization and repolarization, estimated by QRS duration and JT interval, respectively. QT interval abnormalities are associated with potentially fatal ventricular arrhythmia. Using genome-wide multi-ancestry analyses (>250,000 individuals) we identify 177, 156 and 121 independent loci for QT, JT and QRS, respectively, including a male-specific X-chromosome locus. Using gene-based rare-variant methods, we identify associations with Mendelian disease genes. Enrichments are observed in established pathways for QT and JT, and previously unreported genes indicated in insulin-receptor signalling and cardiac energy metabolism. In contrast for QRS, connective tissue components and processes for cell growth and extracellular matrix interactions are significantly enriched. We demonstrate polygenic risk score associations with atrial fibrillation, conduction disease and sudden cardiac death. Prioritization of druggable genes highlight potential therapeutic targets for arrhythmia. Together, these results substantially advance our understanding of the genetic architecture of ventricular depolarization and repolarization.

1 September 2019 in Medical Clinics of North America
Verified
Journal Article
Closed access
MSMelanie M. Steffen
Melanie M. Steffen
JOJeffery S. Osborn
Jeffery S. Osborn
MCMichael J. Cutler
Michael J. Cutler

6 March 2025 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
SCSeung Hoan Choi
Seung Hoan Choi
SJSean Jurgens
Sean Jurgens
LXLing Xiao
Ling Xiao
MHMatthew C Hill
Matthew C Hill
CHChristopher M Haggerty
Christopher M Haggerty
PEPatrick T Ellinor
Patrick T Ellinor

2 January 2025 in Nature Genetics
Verified
Journal Article
Open access
PDF file
LWLu-Chen Weng
Lu-Chen Weng
JRJoel T. Rämö
Joel T. Rämö
SJSean Jurgens
Sean Jurgens
SKShaan Khurshid
Shaan Khurshid
MCMark Chaffin
Mark Chaffin
SLSteven A. Lubitz
Steven A. Lubitz
To broaden our understanding of bradyarrhythmias and conduction disease, we performed common variant genome-wide association analyses in up to 1.3 million individuals and rare variant burden testing in 460,000 individuals for sinus node dysfunction (SND), distal conduction disease (DCD) and pacemaker (PM) implantation. We identified 13, 31 and 21 common variant loci for SND, DCD and PM, respectively. Four well-known loci (SCN5A/SCN10A, CCDC141, TBX20 and CAMK2D) were shared for SND and DCD, while others were more specific for SND or DCD. SND and DCD showed a moderate genetic correlation (rg = 0.63). Cardiomyocyte-expressed genes were enriched for contributions to DCD heritability. Rare-variant analyses implicated LMNA for all bradyarrhythmia phenotypes, SMAD6 and SCN5A for DCD and TTN, MYBPC3 and SCN5A for PM. These results show that variation in multiple genetic pathways (for example, ion channel function, cardiac developmental programs, sarcomeric structure and cellular homeostasis) appear critical to the development of bradyarrhythmias.